Treatment of Atrial Fibrillation by the Ablation of Localized Sources: CONFIRM Trial
Clinical Trials Thursday, January 17th, 2013American College of Cardiology Foundation: January 14, 2013
Atrial fibrillation (AF) is the most common sustained arrhythmia1 and catheter ablation aiming to eliminate tissue critical to AF2 is found to be more effective than medications for its treatment.3-5 Nevertheless, many patients require multiple, lengthy, and costly ablation procedures that confer at least modest risk.2 AF ablation success is likely limited by the current available tools and lack of identification of AF sustenance mechanisms. There are currently two main competing hypotheses on mechanisms of AF sustenance:6 The multiple-wavelet hypothesis proposes that AF perpetuation is maintained by continuous annihilation and regeneration of randomly meandering electrical waves.7 Alternatively, the localized source hypothesis proposes that organized and fast reentrant circuits (rotors)8 or focal impulses9 are discrete and disorganize into fibrillatory waves at their periphery. However, until to date there has been only an indirect10,11or no7 evidence to support localized sources in human AF. Narayan et al12 presents a study testing the hypothesis that human AF, even with a wide range of presentations, is sustained by localized sources whose targeted ablation improves outcomes.



























